At AseBio we want to put biotechnology at the heart of our country's recovery strategy, to drive the green transition of our economy and to strengthen our National Health System
Two chemists who founded Sanifit: “Biotech entrepreneurship isn’t a sprint. It’s an ultram...
Two chemists, when they had barely turned 25, set up a spin-off of the University of the Balearic Islands that has just...
Report | RNA and elite controllers: two keys to fighting HIV
The Covid-19 pandemic seems to have opened up a new door to find a treatment for the virus that causes AIDS. We spoke...
Report | The tool revolutionising biotech by predicting protein structures
AlphaFold 2, a new Artificial Intelligence platform, is being hailed as the most important advance thus far and our...
Biofuel, bioplastics and crops resistant to extreme weather, among the most noteworthy cli...
This Thursday is the next-to-last day of COP26 and the association believes it is important to remember that...
Bayer and Mammoth Biosciences to collaborate on novel gene editing technology
Agreement strengthens Bayer’s new cell and gene therapy platform further / Supports Mammoth’s vision of unlocking the...
Multiomics is revolutionizing research, here’s why
Learn why research leaders decided to use Multiomics in their work.
Introducing Illumina Connected Analytics
Analyze, manage, aggregate, and explore data at scale with Illumina Connected Analytics, a comprehensive, secure, cloud...
The biotech sector is global and internationalization a key axis of the development of its companies. AseBio promotes major events, such as BioSpain, and since 2008 manages the 'ICEX Internationalization Plan for biotechnology companies'. Discover what we can offer you.
